HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Scientists identified a compound, TRi-1, that can kill cancer cells and reduce tumor growth. These images compare tumors treated with a compound that has no effect (top two rows) to tumors treated with the anticancer compound TRi-1 (bottom two rows). The images on the bottom row indicate the TRi-1-treated tumors are mostly smaller after three days of treatment.

NCATS, Karolinska Institutet Scientists Attack Cancer’s Defenses

Scientists from NCATS and Sweden’s Karolinska Institutet have developed a potential new approach to fighting cancer by breaking down a defense system used by cancer cells.


Joe and Ella Murray

Rare Disease Patients and Families Find Hope in Research

NCATS supports rare disease patients and their communities by providing research funding, tools and other resources to help address their unique challenges.


Genome editing

NIH Common Fund Launches Genome Editing Research Program

NCATS is leading trans-agency efforts for NIH’s new Somatic Cell Genome Editing program that aims to develop tools for safe and effective genome editing in human patients.


Person reading the newsletter on a tablet

February E-Newsletter Now Available

Read about NCATS’ support for a promising new gene therapy, a potential strategy against Huntington’s disease, Rare Disease Day at NIH, a CTSA Program scholar, and more.


Woman at a poster session

Rare Disease Day at NIH

This March 1, 2018 event features interactive panel discussions, posters, exhibits, tours and more. Register now.


More Center News

NCATS and NIDCR Collaborate

NIH Collaboration Leverages CTSA Program for Research Mentoring

Gene Therapy

NCATS Collaboration Enables Gene Therapy to Move to Clinical Trial

  • Facebook icon
  • Twitter icon
  • YouTube icon

Director's Corner

Assay Guidance Manual

Assay Guidance Manual Cover

Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.